Thus, these results suggest that therapeutics inhibiting NKG2D signaling might be helpful in dampening disease severity induced by CD8 T cells in cutaneous leishmaniasis caused by L. braziliensis infection. Here, KLRK1 is linked to cutaneous leishmaniasis.